American Conference Institute’s 4th Annual

Paragraph IV Disputes

Expert Insights on Hatch-Waxman Litigation Strategies for Brand Names and Generics

Tuesday, April 27 to Wednesday, April 28, 2010

The Undisputed Source for Hatch-Waxman Litigation Strategies for Brand Name and Generic Drug Companies

Now in its fourth year, ACI’s Paragraph IV Disputes conference has become the most trusted source for the
‘ins and outs’ of Paragraph IV litigation. This first and original conference of its kind serves as the litigation playbook for brand name and generic drug companies in the high-stakes arena of Hatch-Waxman litigation.

The inherent intensity of Paragraph IV litigation has been magnified of late by the seemingly unending
repercussions of the Hatch-Waxman reforms of the MMA, pending Patent Reform legislation, the imminent approval of an abbreviated pathway for follow-on biological products and the threat of proposed legislation,
which may make settlements of these matters near impossible — let alone illegal. These factors have all added to the complexity of this litigation, and have also raised the monetary ante to unprecedented heights.

In this environment, it is imperative that brand name and generic pharmaceutical companies and their counsel, have the offensive moves and defensive plays that they need to meet the challenges of pharmaceutical patent endgame litigation.

ACI’s Paragraph IV Disputes conference has been designed to give counsel for both brand name and generic drug companies the critical up-to-the minute information that they need to plan their Hatch-Waxman litigation strategies.

An experienced faculty comprised of respected and renowned counsel for both brand name and generic pharmaceutical companies will provide insights on every facet of Paragraph IV litigation from pre-litigation concerns to the commencement of suit through to final adjudication — and every step in between. This conference will also provide you with access to renowned federal jurists and a key official from the FTC’s Bureau of Competition’s Health Care Division. You will not only hear firsthand how the bench analyzes the theories of your case, but will also learn what the FTC deems ‘fair and foul’ in the settlement of Paragraph IV disputes.

By popular demand — and in light of current legislative developments — we will once again offer our exclusive Master Class on Settling Paragraph IV Disputes: Brand-Name and Generic Perspectives. This in-depth workshop will offer valuable up-to-the minute insights and strategies from both sides as to what may now well be the most critical consideration in a Paragraph IV challenge.

Also, this year, in response to your requests, we have added the following specialized class: Hatch-Waxman Boot Camp – A Primer on IP Basics and Regulatory Fundamentals.

In this costly and ruthless endgame, not a moment can be lost. Don’t delay – register now by calling 1-888-224-2480, faxing your registration form to 1-877-927-1563, or logging on to www.AmericanConference.com/ParagraphIV.